February 17, 2016 — Up to 10 percent of people with high blood pressure have resistant hypertension — high blood pressure that remains elevated despite treatment with at least three blood pressure medications.
For decades now, magnetic resonance imaging (MRI) has been noted for its excellent soft tissue imaging capability with zero radiation dose. It has been called the imaging modality of the future over and over, but due to its complexity, long exam times and high cost, its growth has been severely limited. This especially has been the case for cardiac MRI, which only accounts for about 1 percent of all MRI exams in the United States. However, new technologies introduced at the 2015 Radiological Society of North America (RSNA) meeting in December may encourage future expansion.Â
If you enjoy this content, please share it with a colleague
Apervita Inc. announced the American College of Cardiology (ACC) will add a recognized tool for predicting atherosclerotic cardiovascular disease (ASCVD) to the growing body of analytics being distributed through the Apervita Marketplace.
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin-Madison have generated master heart cells — primitive progenitors that form the developing heart.
Heart Rhythm Society's 37th Annual Scientific Sessions, to be held in San Francisco, Calif., May 4-7, 2016 will have something for everyone — from networking opportunities to the latest science, education, and technology — focusing on the ideas, people, and technology that continue to propel our field forward.
Location:
Moscone Center
747 Howard Street
San Francisco, CA 94103
There were some big innovation trends in cardiac ultrasound in 2015. These included the launch of the first premium all touchscreen ultrasound system; the introduction of artificial intelligence to speed, simplify and make cardiac echo more reproducible; and a big advancement in image quality, approaching that of computed tomography (CT) scans. Â
If you enjoy this content, please share it with a colleague
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) used ultrasound-activated microbubbles to improve preservation of heart muscle and function in a pig heart attack model. Based on this success, the method is now in phase I human clinical trials.
Royal Philips announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Expression MR400, a new technology that monitors patients undergoing magnetic resonance imaging (MRI).
February 10, 2016 — Fred Hoiberg, head coach of the National Basketball Assocation’s (NBA) Chicago Bulls, is launching a new patient education campaign featuring a video recounting his experience as a heart valve patient. The video premiered January 14 on www.HeartValveSurgery.com.